Ebumab Holding ApS: Financial statements 2021
CVR: 39807556
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Ebumab Holding ApS (CVR 39807556) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -44,907 and a net result of DKK 163,253 compared with DKK -337,322 the year before. Equity in the 2021 report amounted to DKK 5,372,971. The solvency ratio was 82.1%.
- Revenue
- DKK 0
- Gross Profit
- DKK -44,907
- Profit/Loss
- DKK 163,253
- Equity
- DKK 5,372,971
- Total Assets
- DKK 6,541,075
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 0 | -45K | 163K | 5.4M | 0 |
| 2020 | 785K | 392K | -337K | 5.2M | 1 |
Official annual report
Find more companies like Ebumab Holding ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
Ebumab Holding ApS has published its annual report for 2020. Revenue came to DKK 785,388, and the net result was DKK -337,322.
About Ebumab Holding ApS
Ebumab Holding ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2018. The company is registered under the industry Ikke-finansielle hovedsæders aktiviteter. The management consists of Hans Heugh Wandall and Johan Henrik Faber. The board consists of Hans Heugh Wandall (chair), Johan Henrik Faber, Mads Nikolaj Behrndt-Eriksen and Søren Erik Bjørn. The company's owners include Wandall Holding ApS, Johan H. Faber ApS and Batchelor Holding ApS. The company has 1 employee (2024). In 2025, the company reported a gross profit of DKK -86,871 and a net result of DKK 75,634,949 compared with DKK -39,197 the year before. Equity in the 2025 report amounted to DKK 5,684,083.